0
0
12/23/22 at 2:00pm
Organization
Reuters
43 words
0
Comments
BioNTech <a href="https://www.reuters.com/companies/22UAy.DE" target="_blank">(22UAy.DE)</a> on Friday initiated an early-stage study to evaluate its experimental malaria vaccine in humans, the German drugmaker said.
You are the first to view
https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-initiates-clinical-trial-mrna-based-malaria-vaccine-candidate-2022-12-23/
Create an account
or login to join the discussion